What we're reading, February 16, 2016: Affordable Care Act enrollment for 2016 is far below initial estimates; healthcare record hacks increased 11,000% in 2015; and genetic testing hasn't seen wide adoption among consumers.
Affordable Care Act enrollment has fallen far short of initial estimates. The final number of people who signed up for health insurance on the state and federal exchanges was 40% lower than earlier estimates, according to USA Today. The final 12.7 million who signed up is also well below the 2010 estimates for 2016 enrollment from RAND and the Congressional Budget Office: 27 million and 21 million, respectively.
Hacks of healthcare records were up 11,000% last year. Of the one-third of Americans whose healthcare records were compromised with criminals gaining access to valuable personal information, most were unaware, reported NBC News. While Social Security numbers go for $15, complete health records go for $60 each because they can be used to order prescriptions and even file false tax returns. And unlike credits cards, healthcare information cannot be canceled.
Despite being marketed to consumers, genetic tests are still not being widely adopted—and doctors are ok with that. STAT reported the results of a poll with the Harvard T.H. Chan School of Public Health, which found that only 50% of Americans have even heard or read about genetic testing. Furthermore, only 6% have undergone genetic testing. A survey of physicians found that a minority had recommended patients get their genome sequenced, which may account for the low uptake among consumers.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen